{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:25:49Z","timestamp":1773303949046,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00406-020-01184-1","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T15:04:03Z","timestamp":1598886243000},"page":"789-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Understanding the mechanisms of treatment response in depression, focus on electro-convulsive therapy"],"prefix":"10.1007","volume":"270","author":[{"given":"Elisabeth B.","family":"Binder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF (2018) Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry 75:336\u2013346","journal-title":"JAMA Psychiatry"},{"key":"1184_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD Disease","year":"2018","unstructured":"Disease GBD, Injury I, Prevalence C (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 392:1789\u20131858","journal-title":"Lancet (London, England)"},{"key":"1184_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.19m12910","volume":"80","author":"ME Thase","year":"2019","unstructured":"Thase ME, Parikh SV, Rothschild AJ, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Jablonski MR, Greden JF (2019) Impact of pharmacogenomics on clinical outcomes for patients taking medications with gene-drug interactions in a randomized controlled trial. J Clin Psychiatry 80:5","journal-title":"J Clin Psychiatry"},{"key":"1184_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1176\/appi.ajp.2016.16050518","volume":"174","author":"BW Dunlop","year":"2017","unstructured":"Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS (2017) Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder. Am J Psyc 174:533\u2013545","journal-title":"Am J Psyc"},{"key":"1184_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/NDT.S198774","volume":"16","author":"D Voineskos","year":"2020","unstructured":"Voineskos D, Daskalakis ZJ, Blumberger DM (2020) Management of treatment-resistant depression: challenges and strategies. Neuropsyc Dis Treat 16:221\u2013234","journal-title":"Neuropsyc Dis Treat"},{"key":"1184_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-019-01086-x","author":"L Kranaster","year":"2019","unstructured":"Kranaster L, Hoyer C, Mindt S et al (2019) The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid. Eur Arch Psych Clin Neurosci. https:\/\/doi.org\/10.1007\/s00406-019-01086-x","journal-title":"Eur Arch Psych Clin Neurosci"},{"key":"1184_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-019-01087-w","author":"T Soda","year":"2019","unstructured":"Soda T, McLoughlin DM, Clark SR et al (2019) International consortium on the genetics of electroconvulsive therapy and severe depressive disorders (Gen-ECT-ic). Eur Arch Psyc Clin Neurosci. https:\/\/doi.org\/10.1007\/s00406-019-01087-w","journal-title":"Eur Arch Psyc Clin Neurosci"},{"key":"1184_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000491401","volume":"77","author":"L Kranaster","year":"2019","unstructured":"Kranaster L, Hoyer C, Aksay SS, Bumb JM, Muller N, Zill P, Schwarz MJ, Moll N, Lutz B, Bindila L, Zerr I, Schmitz M, Blennow K, Zetterberg H, Haffner D, Leifheit-Nestler M, Ozbalci C, Janke C, Thiel M, Sartorius A (2019) Biomarkers for antidepressant efficacy of electroconvulsive therapy: an exploratory cerebrospinal fluid study. Neuropsychobiology 77:13\u201322","journal-title":"Neuropsychobiology"},{"key":"1184_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00406-018-0962-7","volume":"269","author":"L Kranaster","year":"2019","unstructured":"Kranaster L, Jennen-Steinmetz C, Sartorius A (2019) A novel seizure quality index based on ictal parameters for optimizing clinical decision-making in electroconvulsive therapy. Part 2: Validation. Eur Arch Psychiatry Clin Neurosci 269:859\u2013865","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1184_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1176\/appi.ajp.2017.17030283","volume":"175","author":"PF Sullivan","year":"2018","unstructured":"Sullivan PF, Agrawal A, Bulik CM, Andreassen OA, Borglum AD, Breen G, Cichon S, Edenberg HJ, Faraone SV, Gelernter J, Mathews CA, Nievergelt CM, Smoller JW, O'Donovan MC, Psychiatric GC (2018) Psychiatric Genomics: An Update and an Agenda. Am J Psychiatry 175:15\u201327","journal-title":"Am J Psychiatry"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-020-01184-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01184-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T23:26:35Z","timestamp":1630365995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-020-01184-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s00406-020-01184-1","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"31 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}